Treatment Outcome and Efficacy of Desensitization Strategies for Immunized-PTR in Hematological Malignancies before Hematopoietic Stem Cell Transplantation

Scientists found that immunized-PTR was associated with poor outcomes in hematological malignancies patients after allogeneic hematopoietic stem-cell transplantation transplantation, and desensitization with rituximab and therapeutic plasma exchange achieved favorable outcomes.